Aspen Aerogels price target lowered to $20 from $30 at H.C. Wainwright

H.C. Wainwright analyst Amit Dayal lowered the firm’s price target on Aspen Aerogels to $20 from $30 and keeps a Buy rating on the shares. The company’s revenue outlook for 2024 came in lower than expectations, the analyst tells investors in a research note. However, the firm remains impressed with the roughly 47% revenue growth expected in 2024.